In 90M $101M CDMO joint venture LonzaGroup and ChrHansen to develop and manufacture microbiomebased therapeutics httpow.lyCP5b30ojjGJÂ

In €90M ($101M) CDMO joint venture, @LonzaGroup and @Chr_Hansen to develop and manufacture #microbiome-based therapeutics: http://ow.ly/CP5b30ojjGJ 

17:55 EDT 3 Apr 2019 | Genetic Engineering News

In €90M ($101M) CDMO joint venture, @LonzaGroup and @Chr_Hansen to develop and manufacture #microbiome-based therapeutics: http://ow.ly/CP5b30ojjGJ 

More From BioPortfolio on "In €90M ($101M) CDMO joint venture, @LonzaGroup and @Chr_Hansen to develop and manufacture #microbiome-based therapeutics: http://ow.ly/CP5b30ojjGJ "